Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 7 of 29
-
Moldovan patients and CSOs stood against the patent monopoly on bedaquiline
In 2019, 1.4 million people died from tuberculosis (TB) – which is the leading cause of death among people living...
-
No one left behind: generational transfer of knowledge as essential for universal quality treatment
In Kazakhstan, many people living with HIV waited for years to access treatment with old generation antiretrovirals (ARVs). These medicines...
-
Access to optimal treatment for HIV in Kazakhstan: as prices go down, so does stigma
MMA’s campaign partner in Kazakhstan, Answer, focuses on reducing prices, and improving access to optimal treatment for HCV, viral hepatitis...
-
Leaders of the 21 nations of APEC have pledged urgent action to tackle the pandemic
The 21 leaders of the Asia-Pacific Economic Cooperation met last Friday, 16th of July, (albeit virtually) to pledge urgent action...
-
COVID-19 Community Resource: resource for access to COVID-19 medical technology
COVID-19 has revealed – and drastically worsened – economic and social inequality on a global scale. Governmental decisions to prioritize...
-
In photos: 20 years of fighting for life in Ukraine
100% LIFE’s is the MMA campaign partner in Ukraine. 2021 marks the organization’s 20th anniversary and 30 years of Ukraine’s...
-
Brazilian House of Representatives approves bill to suspend patents: finally lives before profits?
Two months ago, the Brazilian Senate approved a law project bill (Law Project 12/21) that allows the country to expand...
-
Samarn: Activists fought for my right to survive – and won
“Back in 1994, when I was in my early 20s, I fell ill while doing construction work in Bangkok. That’s...
-
Thailand’s opposition against Gilead’s patent application: overcharging what?
Earlier this month, Thai civil society opposed Gilead’s Sciences’ patent application on remdesivir, which has been trialled in the treatment...
-
Treatment activists – here’s your campaign toolkit!
Intellectual property on essential medicines, vaccines and other health technologies affects us all. Where you live directly impacts on the...
-
Editorial corrections: Pfizer’s NYT advert
Pfizer made 9.6 billion in net profit last year alone – 2021 is set to be an even more lucrative...
-
Summit for Vaccine Internationalism
At present rates, it will take 57 years to vaccinate the world against COVID-19. That is why Progressive International is...